Regional Expansion Serosep has recently expanded facilities to Exeter, UK, signaling a growth push into Northern Europe and broader European markets. This opens opportunities for localized support, service contracts, and diagnostic product line expansion in proximity to new facilities.

Wellbeing & Work Culture Recognition as a top workplace for health and wellbeing and a Champion of Employee Well-being and Development indicates a strong employee-centric culture. This can be leveraged to position Serosep as a preferred partner for long-term collaboration with labs seeking reliable, stable suppliers and robust customer support.

Strategic Partnerships Existing collaboration with RCSI on ulcerative colitis diagnostics and Shannon Airport partnerships suggest a network-driven approach. There are opportunities to expand co-development deals, joint research, and distribution through academic and aviation-related healthcare channels.

Small-Market Agility With a lean team and revenue under one million, Serosep can win through targeted, high-margin product lines, rapid deployments, and flexible service offerings. Emphasize scalable solutions for mid-sized labs seeking specialized microbiology diagnostics with responsive support.

Global Competitiveness Positioning as Ireland’s leading microbiology diagnostics provider with a global customer base presents an opportunity to upsell standard diagnostic products to international labs, while offering training, regulatory guidance, and turnkey lab implementation to expand footprints in Europe and beyond.